China Pediatric Pharmaceuticals (CPDU) Return on Assets ROA from the first quarter of 2014 to first quarter of 2013 and for the year 2014, Average High and Low, Fundamental Ratios from Mar 31 2014 to Mar 31 2013 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Pediatric Pharmaceuticals, Inc.  (CPDU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


China Pediatric Pharmaceuticals's ROA from the first quarter of 2014 to the first quarter of 2013 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is China Pediatric Pharmaceuticals's ROA in the first quarter of 2014?
China Pediatric Pharmaceuticals, Inc. achieved a return on average assets (ROA) of 28.07 % in its first quarter of 2014 a new company high.

Despite the company's net income deteriorating, China Pediatric Pharmaceuticals was able to improve its ROA compared to the fourth quarter of 2013.

However, within the Healthcare sector 55 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2014 quarter, so far to 361, from total ROA ranking in the fourth quarter of 2013 at 4161.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter
Y / Y Total Assets Change 34.71 % -3.17 % -59.09 % -67.72 % -63.28 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 2 -1 -10 -13 -12
Return On Assets (TTM) 28.07 % -9.32 % -116.07 % -120.6 % -86.43 %
CPDU's Total Ranking # 361 # 4161 # 4670 # 4574 # 4340
Total Assets (TTM) in million 10 12 7 6 8
Seq. Total Assets Change -13.43 % 73.92 % 5.09 % -14.87 % -37.77 %
Seq. Net Income Change - - - - -

CPDU's 5 Years Annual ROA >> Back to CPDU Management Effectiveness >> Compare CPDU ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 2
Sector # 56
Overall # 267

Return On Assets Statistics
High Average Low
28.07 %
-59.41 %
-120.6 %
(Mar 31 2014)   (Jun 30 2013)





Financial Statements
China Pediatric Pharmaceuticals's Assets $ 10 million CPDU's Balance sheet
China Pediatric Pharmaceuticals's Income $ -2 million Quarterly CPDU's Income Statement
CPDU's Income by Division See CPDU's Income by Division



Annual Return On Assets (Dec 31 2013)
FY 2013		 (Dec 31 2012)
FY 2012		 (Dec 31 2010)
FY 2011
FY
FY
Y / Y Total Assets Change -3.17 % -61.04 % - - -
Total Assets in million 12 12 31 0 0
Y / Y Net Income Change - - - - -
Net Income in million -1 -9 6 0 0
Annual Return On Assets -6.44 % -75.52 % 19.2 % - -

CPDU's 5 Years Annual ROA >> Back to CPDU Management Effectiveness >> Compare CPDU ROA to its Competitors



More Return On Assets Ratios
CPDU's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CPDU's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CPDU's Competitors
Subscribers only: Roa for China Pediatric Pharmaceuticals's Suppliers
Subscribers only: Return On Assets for CPDU's Customers

You may also want to know
CPDU's Roi CPDU's Inventory Turnover Ratio CPDU's Growth Rates CPDU's Dividend Comparisons
CPDU's Profitability Ratios CPDU's Asset Turnover Ratio CPDU's Dividend Growth
CPDU's Roe CPDU's Valuation Ratios CPDU's Financial Strength Ratios CPDU's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2014, within Healthcare Sector ROA
Histogen Inc   76.42 %
Sophiris Bio Inc.  74.44 %
Acceleron Pharma inc  74.32 %
Iveric Bio Inc   74.22 %
Aratana Therapeutics, Inc.  72.62 %
Epizyme Inc.  68.53 %
Clearpoint Neuro Inc   68.00 %
Biocorrx Inc   63.91 %
Filana Therapeutics Inc   56.33 %
Lightwave Logic Inc   52.41 %
Arena Pharmaceuticals Inc   51.74 %
Eternity Healthcare Inc.  43.47 %
Lftd Partners Inc   42.29 %
Portola Pharmaceuticals inc   40.27 %
Skinhealth Systems Inc   39.60 %
Oramed Pharmaceuticals Inc  37.37 %
Agios Pharmaceuticals Inc   37.05 %
Insys Therapeutics, Inc.  36.69 %
Guided Therapeutics Inc   32.42 %
Sorrento Therapeutics Inc   30.11 %
Sonoma Pharmaceuticals Inc   28.29 %
Taro Pharmaceutical Industries Ltd  28.10 %
China Pediatric Pharmaceuticals, Inc.  28.07 %
Veru Inc   27.05 %
Psychemedics Corporation  23.45 %
Milestone Scientific Inc   23.38 %
Myriad Genetics Inc   23.29 %
Bioage Labs Inc   22.80 %
Luna Innovations Inc  21.94 %
Oncomed Pharmaceuticals Inc  21.47 %

Date modified: 2026-09-08T15:08:17+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.